Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Schaeffeler, Elke"'
Autor:
Stühler V; Department of Urology, University Hospital Tuebingen, Eberhard-Karls-University Tuebingen, Tübingen, Germany., Alemi B; Department of Urology, University Hospital Tuebingen, Eberhard-Karls-University Tuebingen, Tübingen, Germany., Rausch S; Department of Urology, University Hospital Tuebingen, Eberhard-Karls-University Tuebingen, Tübingen, Germany., Stenzl A; Department of Urology, University Hospital Tuebingen, Eberhard-Karls-University Tuebingen, Tübingen, Germany., Schwab M; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tübingen, Tübingen, Germany.; Departments of Clinical Pharmacology, Pharmacy and Biochemistry, University of Tuebingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Faculty of Medicine, University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK), Partner Site Tübingen, 72076, Tübingen, Germany., Schaeffeler E; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Faculty of Medicine, University of Tübingen, Tübingen, Germany., Bedke J; Department of Urology, University Hospital Tuebingen, Eberhard-Karls-University Tuebingen, Tübingen, Germany. bedke@live.com.; Department of Urology and Transplantation Surgery, Klinikum Stuttgart, Kriegsbergstraße 60, 70174, Stuttgart, Germany. bedke@live.com.
Publikováno v:
World journal of urology [World J Urol] 2024 Jan 20; Vol. 42 (1), pp. 53. Date of Electronic Publication: 2024 Jan 20.
Autor:
Reustle A; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany; University of Tübingen, Tübingen, Germany., Büttner FA; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany; University of Tübingen, Tübingen, Germany., Schwab M; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany; Departments of Clinical Pharmacology, Pharmacy and Biochemistry, University of Tübingen, Tübingen, Germany. Electronic address: matthias.schwab@ikp-stuttgart.de., Schaeffeler E; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany; University of Tübingen, Tübingen, Germany.
Publikováno v:
European urology [Eur Urol] 2023 Sep; Vol. 84 (3), pp. e72. Date of Electronic Publication: 2023 May 17.
Autor:
Brech D; Immunoanalytics/Tissue Control of Immunocytes, Helmholtz Zentrum München, 81377 Munich, Germany., Herbstritt AS; Immunoanalytics/Tissue Control of Immunocytes, Helmholtz Zentrum München, 81377 Munich, Germany., Diederich S; Immunoanalytics/Tissue Control of Immunocytes, Helmholtz Zentrum München, 81377 Munich, Germany., Straub T; Bioinformatics Core Unit, Biomedical Center, Ludwig-Maximilians-University, 82152 Planegg, Germany., Kokolakis E; Immunoanalytics/Tissue Control of Immunocytes, Helmholtz Zentrum München, 81377 Munich, Germany., Irmler M; Institute of Experimental Genetics, Helmholtz Zentrum München, 85764 Neuherberg, Germany., Beckers J; Institute of Experimental Genetics, Helmholtz Zentrum München, 85764 Neuherberg, Germany.; German Center for Diabetes Research (DZD), 85764 Neuherberg, Germany.; Chair of Experimental Genetics, Technical University of Munich, 85354 Freising, Germany., Büttner FA; Margarete Fischer-Bosch-Institute of Clinical Pharmacology, 70376 Stuttgart, Germany.; University of Tuebingen, 72074 Tuebingen, Germany., Schaeffeler E; Margarete Fischer-Bosch-Institute of Clinical Pharmacology, 70376 Stuttgart, Germany.; University of Tuebingen, 72074 Tuebingen, Germany., Winter S; Margarete Fischer-Bosch-Institute of Clinical Pharmacology, 70376 Stuttgart, Germany.; University of Tuebingen, 72074 Tuebingen, Germany., Schwab M; Margarete Fischer-Bosch-Institute of Clinical Pharmacology, 70376 Stuttgart, Germany.; University of Tuebingen, 72074 Tuebingen, Germany.; Department of Clinical Pharmacology, University of Tuebingen, 72074 Tuebingen, Germany.; Department of Pharmacy and Biochemistry, University of Tuebingen, 72074 Tuebingen, Germany.; German Cancer Consortium (DKTK), Partner Site Tuebingen, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany., Nelson PJ; Medizinische Klinik und Poliklinik IV, University of Munich, 80336 Munich, Germany., Noessner E; Immunoanalytics/Tissue Control of Immunocytes, Helmholtz Zentrum München, 81377 Munich, Germany.
Publikováno v:
Cells [Cells] 2022 Oct 19; Vol. 11 (20). Date of Electronic Publication: 2022 Oct 19.
Autor:
Büttner FA; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Auerbachstrasse 112, 70376, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany., Winter S; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Auerbachstrasse 112, 70376, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany., Stühler V; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany., Rausch S; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany., Hennenlotter J; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany., Füssel S; Department of Urology, University Hospital and Faculty of Medicine, Technische Universität Dresden, Dresden, Germany., Zastrow S; Department of Urology, University Hospital and Faculty of Medicine, Technische Universität Dresden, Dresden, Germany., Meinhardt M; Institute of Pathology, University Hospital and Faculty of Medicine, Technische Universität Dresden, Dresden, Germany., Toma M; Institute of Pathology, University Hospital and Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.; Current address: Institute of Pathology, University of Bonn, Bonn, Germany., Jerónimo C; Cancer Biology & Epigenetics Group-Research Center, Portuguese Oncology Institute of Porto (CI-IPOP, IPO Porto), Porto, Portugal.; Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar-University of Porto (ICBAS-UP), Porto, Portugal.; Department of Pathology, Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal., Henrique R; Cancer Biology & Epigenetics Group-Research Center, Portuguese Oncology Institute of Porto (CI-IPOP, IPO Porto), Porto, Portugal.; Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar-University of Porto (ICBAS-UP), Porto, Portugal.; Department of Pathology, Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal., Miranda-Gonçalves V; Cancer Biology & Epigenetics Group-Research Center, Portuguese Oncology Institute of Porto (CI-IPOP, IPO Porto), Porto, Portugal.; Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar-University of Porto (ICBAS-UP), Porto, Portugal.; Department of Pathology, Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal., Kröger N; Department of Urology, University of Greifswald, Greifswald, Germany., Ribback S; Institute of Pathology, University Medicine Greifswald, Greifswald, Germany., Hartmann A; Institute of Pathology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), University Hospital, Erlangen, Germany., Agaimy A; Institute of Pathology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), University Hospital, Erlangen, Germany., Stöhr C; Institute of Pathology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), University Hospital, Erlangen, Germany., Polifka I; Institute of Pathology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), University Hospital, Erlangen, Germany., Fend F; Institute of Pathology and Neuropathology, University Hospital Tuebingen, Tuebingen, Germany., Scharpf M; Institute of Pathology and Neuropathology, University Hospital Tuebingen, Tuebingen, Germany., Comperat E; Department of Pathology, Medical University of Vienna, Vienna, Austria., Wasinger G; Department of Pathology, Medical University of Vienna, Vienna, Austria., Moch H; Department of Pathology and Molecular Pathology, University Hospital Zuerich, University of Zuerich, Zuerich, Switzerland., Stenzl A; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany., Gerlinger M; Translational cancer immunotherapy and genomics lab, Barts Cancer Institute, Queen Mary University of London, London, UK., Bedke J; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany.; German Cancer Consortium (DKTK), Partner Site Tübingen, German Cancer Research Center (DKFZ), Heidelberg, Germany., Schwab M; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Auerbachstrasse 112, 70376, Stuttgart, Germany. matthias.schwab@ikp-stuttgart.de.; University of Tuebingen, Tuebingen, Germany. matthias.schwab@ikp-stuttgart.de.; German Cancer Consortium (DKTK), Partner Site Tübingen, German Cancer Research Center (DKFZ), Heidelberg, Germany. matthias.schwab@ikp-stuttgart.de.; Departments of Clinical Pharmacology, Pharmacy and Biochemistry, University of Tuebingen, Tuebingen, Germany. matthias.schwab@ikp-stuttgart.de.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany. matthias.schwab@ikp-stuttgart.de., Schaeffeler E; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Auerbachstrasse 112, 70376, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany.; German Cancer Consortium (DKTK), Partner Site Tübingen, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany.
Publikováno v:
Genome medicine [Genome Med] 2022 Sep 15; Vol. 14 (1), pp. 105. Date of Electronic Publication: 2022 Sep 15.
Autor:
Reustle A; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany., Menig LS; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany., Leuthold P; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany., Hofmann U; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany., Stühler V; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany., Schmees C; NMI Natural and Medical Sciences Institute at the University of Tuebingen, Reutlingen, Germany., Becker M; Experimental Pharmacology and Oncology GmbH, Berlin-Buch, Germany., Haag M; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany., Klumpp V; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany., Winter S; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany., Büttner FA; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany., Rausch S; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany., Hennenlotter J; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany., Fend F; Institute of Pathology and Neuropathology, University Hospital Tuebingen, Tuebingen, Germany., Scharpf M; Institute of Pathology and Neuropathology, University Hospital Tuebingen, Tuebingen, Germany., Stenzl A; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany., Bedke J; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany.; German Cancer Consortium (DKTK), Partner Site Tübingen, German Cancer Research Center (DKFZ), Heidelberg, Germany., Schwab M; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany.; German Cancer Consortium (DKTK), Partner Site Tübingen, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Departments of Clinical Pharmacology, Pharmacy and Biochemistry, University of Tuebingen, Tuebingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany., Schaeffeler E; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany.
Publikováno v:
Clinical and translational medicine [Clin Transl Med] 2022 Jun; Vol. 12 (6), pp. e883.
Autor:
Ribback S; Institute of Pathology, University Medicine, Greifswald, Germany., Winter S; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, University of Tübingen, Tübingen, Germany., Klatte T; Department of Urology, Royal Bournemouth Hospital, Bournemouth, UK., Schaeffeler E; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, University of Tübingen, Tübingen, Germany., Gellert M; Institute of Medical Biochemistry and Molecular Biology, University Medicine, Greifswald, Germany., Stühler V; Department of Urology, University of Tübingen, Tübingen, Germany., Scharpf M; Institute of Pathology, University of Tübingen, Tübingen, Germany., Bedke J; Department of Urology, University of Tübingen, Tübingen, Germany., Burchardt M; Department of Urology, University Medicine, Ferdinand-Sauerbruch-Straße, E17475, Greifswald, Germany., Schwab M; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, University of Tübingen, Tübingen, Germany.; Departments of Clinical Pharmacology, Pharmacy and Biochemistry, University of Tübingen, Tübingen, Germany., Lillig CH; Institute of Medical Biochemistry and Molecular Biology, University Medicine, Greifswald, Germany., Kroeger N; Institute of Medical Biochemistry and Molecular Biology, University Medicine, Greifswald, Germany. md.nkroeger@gmail.com.; Department of Urology, University Medicine, Ferdinand-Sauerbruch-Straße, E17475, Greifswald, Germany. md.nkroeger@gmail.com.
Publikováno v:
World journal of urology [World J Urol] 2022 Mar; Vol. 40 (3), pp. 739-746. Date of Electronic Publication: 2021 Dec 02.
Autor:
Reustle A; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany., Di Marco M; Department of Immunology, Institute for Cell Biology, University of Tuebingen, Tuebingen, Germany., Meyerhoff C; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany., Nelde A; Department of Immunology, Institute for Cell Biology, University of Tuebingen, Tuebingen, Germany.; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), University Hospital Tuebingen, Tuebingen, Germany.; German Cancer Consortium (DKTK), Partner Site Tuebingen, Tuebingen, Germany., Walz JS; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), University Hospital Tuebingen, Tuebingen, Germany.; German Cancer Consortium (DKTK), Partner Site Tuebingen, Tuebingen, Germany.; iFIT Cluster of Excellence (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany., Winter S; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany., Kandabarau S; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany., Büttner F; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany., Haag M; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany., Backert L; Department of Immunology, Institute for Cell Biology, University of Tuebingen, Tuebingen, Germany., Kowalewski DJ; Department of Immunology, Institute for Cell Biology, University of Tuebingen, Tuebingen, Germany., Rausch S; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany., Hennenlotter J; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany., Stühler V; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany., Scharpf M; Institute of Pathology and Neuropathology, University Hospital Tuebingen, Tuebingen, Germany., Fend F; Institute of Pathology and Neuropathology, University Hospital Tuebingen, Tuebingen, Germany., Stenzl A; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany., Rammensee HG; Department of Immunology, Institute for Cell Biology, University of Tuebingen, Tuebingen, Germany.; German Cancer Consortium (DKTK), Partner Site Tuebingen, Tuebingen, Germany.; iFIT Cluster of Excellence (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany., Bedke J; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany., Stevanović S; Department of Immunology, Institute for Cell Biology, University of Tuebingen, Tuebingen, Germany.; German Cancer Consortium (DKTK), Partner Site Tuebingen, Tuebingen, Germany.; iFIT Cluster of Excellence (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany., Schwab M; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany. matthias.schwab@ikp-stuttgart.de.; University of Tuebingen, Tuebingen, Germany. matthias.schwab@ikp-stuttgart.de.; German Cancer Consortium (DKTK), Partner Site Tuebingen, Tuebingen, Germany. matthias.schwab@ikp-stuttgart.de.; iFIT Cluster of Excellence (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany. matthias.schwab@ikp-stuttgart.de.; Departments of Clinical Pharmacology, Pharmacy and Biochemistry, University of Tuebingen, Tuebingen, Germany. matthias.schwab@ikp-stuttgart.de., Schaeffeler E; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany.; iFIT Cluster of Excellence (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany.
Publikováno v:
Genome medicine [Genome Med] 2020 Mar 30; Vol. 12 (1), pp. 32. Date of Electronic Publication: 2020 Mar 30.
Autor:
Heinzelmann J; Department of Urology and Pediatric Urology, Saarland University, Homburg, Saar, Germany.; Department of Ophthalmology, Martin-Luther University Halle-Wittenberg, University Hospital Halle (Saale), Halle (Saale), Germany., Arndt M; Department of Urology and Pediatric Urology, Saarland University, Homburg, Saar, Germany., Pleyers R; Department of Urology and Pediatric Urology, Saarland University, Homburg, Saar, Germany., Fehlmann T; Department of Clinical Bioinformatics, Saarland University, Saarbruecken, Germany., Hoelters S; Department of Urology and Pediatric Urology, Saarland University, Homburg, Saar, Germany.; SERVA Electrophoresis GmbH, Heidelberg, Germany., Zeuschner P; Department of Urology and Pediatric Urology, Saarland University, Homburg, Saar, Germany., Vogt A; Department of Urology and Pediatric Urology, Saarland University, Homburg, Saar, Germany., Pryalukhin A; Institute of Pathology, Saarland University, Homburg, Saar, Germany.; Institute of Pathology, Bonn University Medical School, Bonn, Germany., Schaeffeler E; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany., Bohle RM; Institute of Pathology, Saarland University, Homburg, Saar, Germany., Gajda M; Institute of Pathology, Jena University Hospital, Jena, Germany., Janssen M; Department of Urology and Pediatric Urology, Saarland University, Homburg, Saar, Germany., Stoeckle M; Department of Urology and Pediatric Urology, Saarland University, Homburg, Saar, Germany., Junker K; Department of Urology and Pediatric Urology, Saarland University, Homburg, Saar, Germany. kerstin.junker@uks.eu.; Department of Urology, Jena University Hospital, Jena, Germany. kerstin.junker@uks.eu.
Publikováno v:
Annals of surgical oncology [Ann Surg Oncol] 2019 Oct; Vol. 26 (11), pp. 3765-3773. Date of Electronic Publication: 2019 Jul 03.
Autor:
Neumann E; Department of Urology, Eberhard Karls University, Hoppe-Seyler- Strasse 3, 72076, Tuebingen, Germany., Klaiber P; Department of Urology, Eberhard Karls University, Hoppe-Seyler- Strasse 3, 72076, Tuebingen, Germany., Freitag K; Department of Urology, Eberhard Karls University, Hoppe-Seyler- Strasse 3, 72076, Tuebingen, Germany., Schwab M; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.; Department of Clinical Pharmacology, Eberhard Karls University, Tuebingen, Germany.; Department of Pharmacy and Biochemistry, Eberhard Karls University, Tuebingen, Germany., Schaeffeler E; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany., Hennenlotter J; Department of Urology, Eberhard Karls University, Hoppe-Seyler- Strasse 3, 72076, Tuebingen, Germany., Fend F; Department of Pathology, Eberhard Karls University, Tuebingen, Germany., Kruck S; Department of Urology, Eberhard Karls University, Hoppe-Seyler- Strasse 3, 72076, Tuebingen, Germany., Scharpf M; Department of Pathology, Eberhard Karls University, Tuebingen, Germany., Stenzl A; Department of Urology, Eberhard Karls University, Hoppe-Seyler- Strasse 3, 72076, Tuebingen, Germany., Bedke J; Department of Urology, Eberhard Karls University, Hoppe-Seyler- Strasse 3, 72076, Tuebingen, Germany., Rausch S; Department of Urology, Eberhard Karls University, Hoppe-Seyler- Strasse 3, 72076, Tuebingen, Germany. steffen.rausch@med.uni-tuebingen.de.
Publikováno v:
Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2019 Jul; Vol. 145 (7), pp. 1835-1843. Date of Electronic Publication: 2019 Apr 22.
Autor:
Schaeffeler E; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany; University of Tuebingen, Tuebingen, Germany., Büttner F; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany; University of Tuebingen, Tuebingen, Germany., Reustle A; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany; University of Tuebingen, Tuebingen, Germany., Klumpp V; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany; University of Tuebingen, Tuebingen, Germany., Winter S; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany; University of Tuebingen, Tuebingen, Germany., Rausch S; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany., Fisel P; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany; University of Tuebingen, Tuebingen, Germany., Hennenlotter J; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany., Kruck S; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany., Stenzl A; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany., Wahrheit J; Biocrates Life Sciences AG, Innsbruck, Austria., Sonntag D; Biocrates Life Sciences AG, Innsbruck, Austria., Scharpf M; Institute of Pathology and Neuropathology, University Hospital Tuebingen, Tuebingen, Germany., Fend F; Institute of Pathology and Neuropathology, University Hospital Tuebingen, Tuebingen, Germany., Agaimy A; Institute of Pathology, University Erlangen-Nuernberg, Erlangen, Germany., Hartmann A; Institute of Pathology, University Erlangen-Nuernberg, Erlangen, Germany., Bedke J; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany., Schwab M; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany; University of Tuebingen, Tuebingen, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Clinical Pharmacology, University Hospital Tuebingen, Tuebingen, Germany; Department of Pharmacy and Biochemistry, University of Tuebingen, Tuebingen, Germany. Electronic address: matthias.schwab@ikp-stuttgart.de.
Publikováno v:
European urology focus [Eur Urol Focus] 2019 Jul; Vol. 5 (4), pp. 608-618. Date of Electronic Publication: 2018 Feb 13.